What's in Repurposed Therapeutics, Inc.'s pipeline?

Repurposed Therapeutics, Inc. has 3 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Repurposed Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Alza Corporation, DE, USA, Edgar LeClaire, MD, GlaxoSmithKline, Janssen-Cilag Ltd.,Thailand, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/repurposed-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Repurposed Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Repurposed Therapeutics, Inc. pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Transdermal Scopolamine	Transdermal Scopolamine	marketed	Anticholinergic agent	Muscarinic acetylcholine receptor (M1)	Gastroenterology / Neurology
DPI-386 Nasal Gel	DPI-386 Nasal Gel	phase 3
scopolamine HBr	scopolamine HBr	phase 3	Anticholinergic agent	Muscarinic acetylcholine receptors (M1-M5)	Neurology / Gastroenterology

Therapeutic area mix

Gastroenterology / Neurology · 1
Neurology / Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Alza Corporation, DE, USA · 1 shared drug class
Edgar LeClaire, MD · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Janssen-Cilag Ltd.,Thailand · 1 shared drug class
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · 1 shared drug class
Rutgers, The State University of New Jersey · 1 shared drug class
Stony Brook University · 1 shared drug class
Toronto Rehabilitation Institute · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Repurposed Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Repurposed Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/repurposed-therapeutics-inc. Accessed 2026-06-10.